[EN] SUBSTITUTED HYDANTOINS AS MEK KINASE INHIBITORS<br/>[FR] HYDANTOÏNES SUBSTITUÉES EN TANT QU'INHIBITEURS DE LA MEK KINASE
                        
                            
                                申请人:HOFFMANN LA ROCHE
                            
                            
                                公开号:WO2009080523A1
                            
                            
                                公开(公告)日:2009-07-02
                            
                            The present invention relates to compounds of the formula (I) methods for the preparation thereof, and methods for their use. The compounds are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as cancer, cognitive and CNS disorders, and inflammatory/autoimmune diseases.